![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Diffuse Cutaneous Systemic Sclerosis - 25 Studies Found
Active, not recruiting |
: A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis : Diffuse Cutaneous Systemic Sclerosis : 2014-06-03 :
|
Completed |
: Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis : Early Diffuse Cutaneous Systemic Sclerosis : 2014-12-22 :
|
Recruiting |
: Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis :
: 2015-06-30 : |
Active, not recruiting |
: Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis : Diffuse Cutaneous Systemic Sclerosis : 2015-06-04 :
|
Completed |
: Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis : Systemic Sclerosis : 2012-08-15 : Drug: Belimumab Belimumab (Benlysta®) decreases B-Cell survival and has been FDA approved for the t |
Completed |
: Mycophenolate Mofetil in Systemic Sclerosis : Diffuse Cutaneous Systemic Sclerosis : 2007-02-07 : Drug: Mycophenolate Mofetil Mycophenolate 3000 mg each day |
Completed |
: AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis : Systemic Sclerosis : 2008-10-07 :
|
Not yet recruiting |
: Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis : Scleroderma, Systemic : 2017-01-31 :
|
Withdrawn |
: A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) : Scleroderma : 2015-10-26 :
|
Recruiting |
: Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension :
|